Spectrum Pharmaceuticals reported $-25318000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Actinium Pharmaceuticals ATNM:US $ -5027000 2.88M
Agios Pharmaceuticals AGIO:US $ -95.35M 3.32M
Alnylam Pharmaceuticals ALNY:US $ -181.59M 44.32M
Amgen AMGN:US $ 3004M 337M
Arrowhead Research ARWR:US $ -70306000 114.46M
Astellas Pharma 4503:JP Y 69499M 60663M
AstraZeneca AZN:LN 3562M 625M
Bayer BAYN:GR € 4762M 490M
Biogen BIIB:US $ 1075.7M 401M
Bristol Myers Squibb BMY:US $ 5780M 8M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
GlaxoSmithKline GSK:LN 2447M 673M
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
Johnson & Johnson JNJ:US $ 8036M 1273M
Karyopharm Therapeutics KPTI:US $ -42759000 8.35M
Mirati Therapeutics MRTX:US $ -176.51M 7.08M
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Puma Biotechnology PBYI:US $ 14.28M 12.77M
Seattle Genetics SGEN:US $ -115.89M 0.06M
Spectrum Pharmaceuticals SPPI:US $ -25.32M 11.33M
Takeda 4502:JP Y 308798M 158143M
Teva Pharmaceutical TEVA:IT 1.09B 20M
YTE INCY:US $ 276.8M 132.69M